NEW YORK (360Dx) –  Vermillion reported after the close of the market on Wednesday a 12 percent year-over-year jump in its third quarter revenues

For the three months ended Sept. 30, the Austin, Texas-based cancer diagnostics firm said that total revenues rose to $699,000 from $623,000 in the year-ago quarter.

Product revenues were $657,000, up 13 percent from $581,000 in Q3 2016. Service revenues from the company's Aspira IVD business were flat at $42,000.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.